Betulinic acid as new activator of NF-κB: Molecular mechanisms and implications for cancer therapy

Oncogene

Volumn 24, Issue 46, 2005, Pages 6945-6956

  Kasperczyk, Hubert ^a   La Ferla Brühl, Katia ^a   Westhoff, Mike Andrew ^a   Behrend, Lars ^b   Zwacka, Ralf Michael ^b   Debatin, Klaus Michael ^a   Fulda, Simone ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Betulinic acid; Cancer; NF B

Indexed keywords

ANTIOXIDANT; BETULIC ACID; DNA; I KAPPA B ALPHA; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; PROTEIN P50; PROTEIN SUBUNIT; SERINE; SYNAPTOTAGMIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; HYDROLYSIS; I-KAPPA B PROTEINS; NEOPLASMS; NF-KAPPA B; TRITERPENES;

EID: 27144547145     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208842     Document Type: Article

References (31)

1. Algul H, Adler G and Schmid RM. (2002). Int. J. Gastrointest. Cancer, 31, 71-78.
2. Baetu TM, Kwon H, Sharma S, Grandvaux N and Hiscott J. (2001). J. Immunol., 167, 3164-3173.
3. Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, Debatin KM, Proksch P and Wirth T. (2002). J. Biol. Chem., 277, 44791-44800.
4. Campbell KJ, Rocha S and Perkins ND. (2004). Mol. Cell, 13, 853-865.
5. Debatin KM, Poncet D and Kroemer G. (2002). Oncogene, 21, 8786-8803.
6. Fulda S and Debatin KM. (2002). Oncogene, 21, 2295-2308.
7. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME and Debatin KM. (1997). Cancer Res., 57, 4956-4964.
8. Fulda S, Jeremias I and Debatin KM. (2004). Oncogene, 23, 7611-7620.
9. Fulda S, Jeremias I, Steiner HH, Pietsch T and Debatin KM. (1999). Int. J. Cancer, 82, 435-441.
10. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME and Debatin KM. (1998a). J. Biol. Chem., 273, 33942-33948.
11. Fulda S, Susin SA, Kroemer G and Debatin KM. (1998b). Cancer Res., 58, 4453-4460.
12. Hayden MS and Ghosh S. (2004). Genes Dev., 18, 2195-2224.
13. Hengartner MO. (2000). Nature, 407, 770-776.
14. Herr I and Debatin KM. (2001). Blood, 98, 2603-2614.
15. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T and Debatin KM. (1998). Blood, 91, 4624-4631.
16. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
17. Karin M, Cao Y, Greten FR and Li ZW. (2002). Nat. Rev. Cancer, 2, 301-310.
18. Karin M, Yamamoto Y and Wang QM. (2004). Nat. Rev. Drug Disc., 3, 17-26.
19. Kim B and Feldman EL. (2002). J. Biol. Chem., 277, 27393-27400.
20. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TK and Pezzuto JM. (1995). Nat. Med., 1, 1046-1051.
21. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C, Fuchs EJ and Bedi A. (2001). Nat. Cell Biol., 3, 409-416.
22. Sawada N, Kataoka K, Kondo K, Arimochi H, Fujino H, Takahashi Y, Miyoshi T, Kuwahara T, Monden Y and Ohnishi Y. (2004). Br. J. Cancer., 90, 1672-1678.
23. Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B and Kodym R. (2000). J. Invest. Dermatol., 114, 935-940.
24. Takada Y and Aggarwal BB. (2003). J. Immunol., 171, 3278-3286.
25. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P. (2002). Cell Death Differ., 9, 1031-1042.
26. Wahl C, Liptay S, Adler G and Schmid RM. (1998). J. Clin. Invest., 101, 1163-1174.
27. Weaver KD, Yeyeodu S, Cusack Jr JC, Baldwin Jr AS and Ewend MG. (2003). J. Neuro-Oncol., 61, 187-196.
28. Younes A, Garg A and Aggarwal BB. (2003). Leuk. Lymphoma, 44, 929-935.
29. Zhang Y and Chen F. (2004). Cancer Res., 64, 1902-1905.
30. Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C and Formelli F. (2002). Cancer Lett., 175, 17-25.
31. Zwacka RM, Stark L and Dunlop MG. (2000). J. Gene Med., 2, 334-343.